• Generate Integrating AI into Biologics

  • Aug 23 2024
  • Length: 55 mins
  • Podcast

Generate Integrating AI into Biologics

  • Summary

  • Generate Biomedicines’ proprietary platform aims to use generative biology to upend traditional drug development across therapeutic protein modalities. Gevorg Grigoryan, chief technology officer, and Alex Snyder, chief medical officer, sit down with BI analysts Andrew Galler and Sam Fazeli to discuss the general state of AI in drug development and the unique capabilities of the Generate platform in developing novel biologics.

    See omnystudio.com/listener for privacy information.

    Show more Show less
activate_WEBCRO358_DT_T2

What listeners say about Generate Integrating AI into Biologics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.